The role of CD44 in pathological angiogenesis

被引:85
作者
Chen, Li [1 ,2 ,3 ]
Fu, Chenying [4 ]
Zhang, Qing [1 ,2 ]
He, Chengqi [1 ,2 ]
Zhang, Feng [3 ]
Wei, Quan [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Rehabil Med Ctr, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Key Lab Rehabil Med Sichuan Prov, Chengdu, Peoples R China
[3] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Peoples R China
[4] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China
基金
中国国家自然科学基金;
关键词
angiogenesis; cancer; CD44; HA; ischemia; ocular disease; MEMBRANE-TYPE-1; MATRIX-METALLOPROTEINASE; ENDOTHELIAL-CELL PROLIFERATION; HYALURONIC-ACID BINDING; CANCER STEM-CELLS; BREAST-CANCER; GROWTH-FACTOR; BIVATUZUMAB MERTANSINE; VASCULOGENIC MIMICRY; ERM PROTEINS; UP-REGULATION;
D O I
10.1096/fj.202000380RR
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiogenesis is required for normal development and occurs as a pathological step in a variety of disease settings, such as cancer, ocular diseases, and ischemia. Recent studies have revealed the role of CD44, a widely expressed cell surface adhesion molecule, in promoting pathological angiogenesis and the development of its associated diseases through its regulation of diverse function of endothelial cells, such as proliferation, migration, adhesion, invasion, and communication with the microenvironment. Conversely, the absence of CD44 expression or inhibition of its function impairs pathological angiogenesis and disease progression. Here, we summarize the current understanding of the roles of CD44 in pathological angiogenesis and the underlying cellular and molecular mechanisms.
引用
收藏
页码:13125 / 13139
页数:15
相关论文
共 178 条
[21]   Endovascular vs medical management of acute ischemic stroke [J].
Chen, Ching-Jen ;
Ding, Dale ;
Starke, Robert M. ;
Mehndiratta, Prachi ;
Crowley, R. Webster ;
Liu, Kenneth C. ;
Southerland, Andrew M. ;
Worrall, Bradford B. .
NEUROLOGY, 2015, 85 (22) :1980-1990
[22]  
Chen JQ, 2014, BMC CANCER, V14, DOI [10.1186/1471-2407-14-802, 10.1186/1471-2407-14-15]
[23]   Increased hyaluronan and CD44 expressions in intravenous leiomyomatosis [J].
Chen, MJ ;
Peng, Y ;
Yang, YS ;
Huang, SC ;
Chow, SN ;
Torng, PL .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2005, 84 (04) :322-328
[24]   RETRACTED: MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cells (Retracted Article) [J].
Chetty, Chandramu ;
Vanamala, Sravan K. ;
Gondi, Christopher S. ;
Dinh, Dzung H. ;
Gujrati, Meena ;
Rao, Jasti S. .
CELLULAR SIGNALLING, 2012, 24 (02) :549-559
[25]   CD44 isoforms in human retinal and choroidal endothelial cells [J].
Chipps, Timothy J. ;
Appukuttan, Binoy ;
Pan, Yuzhen ;
Smith, Justine R. .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 251 (04) :1245-1246
[26]   Developmental and Pathological Angiogenesis [J].
Chung, Alicia S. ;
Ferrara, Napoleone .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27, 2011, 27 :563-584
[27]   CD44 and its ligand hyaluronate mediate rolling under physiologic flow: A novel lymphocyte-endothelial cell primary adhesion pathway [J].
DeGrendele, HC ;
Estess, P ;
Picker, LJ ;
Siegelman, MH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) :1119-1130
[28]   Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature [J].
Deryugina, Elena I. ;
Quigley, James P. .
MATRIX BIOLOGY, 2015, 44-46 :94-112
[29]   Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells [J].
Desai, Bhavik ;
Rogers, Michael J. ;
Chellaiah, Meenakshi A. .
MOLECULAR CANCER, 2007, 6
[30]  
Dew L, 2015, REGEN MED, V10, P211, DOI [10.2217/RME.14.83, 10.2217/rme.14.83]